Monopar Therapeutics (MNPR) Cash & Equivalents (2016 - 2026)
Monopar Therapeutics (MNPR) posted Cash & Equivalents of $52.76 million for Q2 2026, up 33.6% from $39.5 million a year earlier.
Powered by 
Analysis
Monopar Therapeutics (MNPR) Cash & Equivalents (2016 - 2026) Analysis & Trends
At the end of FY2025, Monopar Therapeutics' Cash & Equivalents came in at $61.83 million, up 35.0% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of 29.9% (FY2020 to FY2025).
- In prior years, Monopar Therapeutics' Cash & Equivalents was $45.82 million in FY2024 (+530.6%), $7.27 million in FY2023 (-11.2%), $8.19 million in FY2022 (-59.7%) and $20.3 million in FY2021 (+21.3%).
- Quarterly Cash & Equivalents has run from a low of $5.52 million in Q3 2023 to a high of $127.68 million in Q3 2025 over five years.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q2 2025, with growth of 545.5%; the weakest was Q1 2023, with a decline of 67.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Monopar Therapeutics | 666.05 Mn | 384.28 Mn | - | 52.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 52.76 Mn |
| Dec 31, 2025 | 61.83 Mn |
| Sep 30, 2025 | 127.68 Mn |
| Jun 30, 2025 | 39.50 Mn |
| Mar 31, 2025 | 39.71 Mn |
| Dec 31, 2024 | 45.82 Mn |
| Sep 30, 2024 | 6.02 Mn |
| Jun 30, 2024 | 6.12 Mn |
| Mar 31, 2024 | 7.81 Mn |
| Dec 31, 2023 | 7.27 Mn |
| Sep 30, 2023 | 5.52 Mn |
| Jun 30, 2023 | 7.21 Mn |
| Mar 31, 2023 | 5.73 Mn |
| Dec 31, 2022 | 8.19 Mn |
| Sep 30, 2022 | 14.32 Mn |
| Jun 30, 2022 | 16.46 Mn |
| Mar 31, 2022 | 17.82 Mn |
| Dec 31, 2021 | 20.30 Mn |
| Sep 30, 2021 | 22.34 Mn |
| Jun 30, 2021 | 24.29 Mn |
API Access
Monopar Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MNPR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "MNPR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MNPR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();